BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
24.02.12 UBS buy Banc of America Securities-Merrill Lynch
24.02.12 Zurich Insurance outperform Macquarie Research
24.02.12 Swiss Re neutral Nomura
24.02.12 Swiss Re underperform RBC Capital Markets
24.02.12 Swiss Life buy Nomura
24.02.12 ABB (Asea Brown Boveri) outperform Sanford C. Bernstein and Co., Inc.
23.02.12 Roche overweight J.P. Morgan Cazenove
23.02.12 Swiss Re buy Sarasin Research
22.02.12 Zurich Insurance neutral J.P. Morgan Cazenove
22.02.12 Straumann neutral Sarasin Research
22.02.12 Zurich Insurance hold Commerzbank Corp. & Markets
22.02.12 Holcim hold Deutsche Bank AG
21.02.12 ABB (Asea Brown Boveri) overweight J.P. Morgan Cazenove
21.02.12 Schindler buy Sarasin Research
21.02.12 Givaudan neutral Credit Suisse Group
21.02.12 ABB (Asea Brown Boveri) outperform Cheuvreux SA
21.02.12 Swisscom buy Nomura
21.02.12 Julius Bär buy Sarasin Research
21.02.12 Zurich Insurance outperform RBC Capital Markets
21.02.12 Zurich Insurance halten Independent Research GmbH
20.02.12 Holcim neutral Citigroup Corp.
20.02.12 Zurich Insurance buy ING
20.02.12 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
20.02.12 UBS halten Hamburger Sparkasse AG (Haspa)
20.02.12 Nestlé halten Independent Research GmbH
20.02.12 Givaudan neutral UBS AG
17.02.12 Zurich Insurance neutral Merrill Lynch & Co., Inc.
17.02.12 Givaudan sell Citigroup Corp.
17.02.12 Givaudan overweight J.P. Morgan Cazenove
17.02.12 ABB (Asea Brown Boveri) overweight J.P. Morgan Cazenove
17.02.12 Zurich Insurance buy Nomura
17.02.12 ABB (Asea Brown Boveri) halten Independent Research GmbH
16.02.12 Swisscom buy Société Générale Group S.A. (SG)
16.02.12 Nestlé hold ING
16.02.12 Zurich Insurance buy Sarasin Research
16.02.12 Givaudan neutral Sarasin Research
15.02.12 Swisscom neutral Sarasin Research
15.02.12 Swiss Re equal-weight Morgan Stanley
14.02.12 UBS underperform Exane-BNP Paribas SA
14.02.12 UBS underperform Exane-BNP Paribas SA